Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (NCT07889518) titled 'Treatment of Recurrent and Multifocal Central Serous Chorioretinopathy' on Oct. 16.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Benha University

Condition: Central Serous Retinopathy (CSR) Sub-Threshold Laser

Intervention: Device: 577 nm Subthreshold Micropulse Laser

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: July 1, 2024

Target Sample Size: 40

Countries of Recruitment: Egypt

To know more, visit https://clinicaltrials.gov/study/NCT07889518

Dis...